Clinical Trial Update: A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3) [Phase 2]

View source ↗

Summary

Phase 2 randomized trial comparing combination and nucleoside therapies for advanced HIV disease (CD4 ≤ 50/mm3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED